MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN) highlights presentations at the American Society of Clinical Oncology (ASCO)/American Association for Cancer Research (AACR) Joint Session: Telomeres and Telomerase in Cancer taking place today at the 2011 ASCO Annual Meeting in Chicago, IL. The special session will be co-chaired by ASCO’s outgoing president, George W. Sledge, M.D., and Elizabeth H. Blackburn, Ph.D., joint-winner of the 2009 Nobel Prize in Physiology or Medicine for her discoveries in the field of telomere biology and telomerase, and a former Geron collaborator. The joint session will begin at 9:45 a.m. CDT, and a webcast will be available for conference registrants.
